ADMA Biologics, Inc. (ADMA)
18.28
+0.58
(+3.25%)
USD |
NASDAQ |
Jan 14, 16:00
18.28
0.00 (0.00%)
After-Hours: 19:36
ADMA Biologics Market Cap: 4.349B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 455.34M |
| Aldeyra Therapeutics, Inc. | 255.69M |
| Arcutis Biotherapeutics, Inc. | 3.272B |
| Marker Therapeutics, Inc. | 30.68M |
| CorMedix, Inc. | 558.61M |
Market Cap Related Metrics
| PE Ratio | 21.46 |
| PS Ratio | 9.200 |
| PEG Ratio | 0.1031 |
| Price to Book Value | 10.09 |
| Price to Free Cash Flow | 110.69 |
| Price | 18.28 |
| Earnings Yield | 4.66% |
| PEGY Ratio | 0.1031 |
| Operating PE Ratio | 26.91 |
| Normalized PE Ratio | 21.14 |